Cargando…

Clinical trial update: National Cancer Institute of Canada

The Breast Cancer Site Group (BCSG) of the National Cancer Institute of Canada (NCIC) Clinical Trials Group (CTG) has conducted a wide variety of clinical trials focussing on large phase III trials of adjuvant chemotherapy, adjuvant hormonal therapy, and optimal delivery of adjuvant radiation therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pritchard, Kathy, Whelan, Tim
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064133/ https://www.ncbi.nlm.nih.gov/pubmed/15743510 http://dx.doi.org/10.1186/bcr979

Ejemplares similares

Concussion research at the National Institutes of Health: an update from the National Institute of Neurological Disorders and Stroke
por: Mott, Meghan, et al.
Publicado: (2015)

Creating implementable clinical practice guidelines: the 2020 Focused Updates to the National Heart, Lung, and Blood Institute’s Asthma Management Guidelines
por: Shero, Susan T., et al.
Publicado: (2023)

Applying the Strategic Planning Process to a Large Research Consortium: The Example of the National Cancer Institute Cohort Consortium
por: Harvey, Chinonye E., et al.
Publicado: (2021)

COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute
por: Schnoll, Robert, et al.
Publicado: (2021)

Clinical trial update: International Breast Cancer Study Group
por: Price, Karen N, et al.
Publicado: (2005)

Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute
por: Norton, Wynne E., et al.
Publicado: (2019)

The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial
por: Richardson, H., et al.
Publicado: (2007)

Long-term outcomes of trials in the National Institute for Health and Care Excellence depression guideline
por: McPherson, Susan, et al.
Publicado: (2019)

The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute
por: Tolaney, Sara M, et al.
Publicado: (2020)

Canada’s National Advisory Committee on Immunization: Celebrating 50 years
por: Desai, Shalini, et al.
Publicado: (2015)

Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group
por: Rutgers, Emiel JT, et al.
Publicado: (2004)

Issues of methods and interpretation in the National Cancer Institute formaldehyde cohort study
por: Marsh, Gary M, et al.
Publicado: (2014)

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
por: Leary, Alexandra F, et al.
Publicado: (2007)

National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
por: Rawson, Nigel S. B.
Publicado: (2020)

The importance of PROSPERO to the National Institute for Health Research
por: Davies, Sally
Publicado: (2012)

The National Institutes of Health and guidance for reporting preclinical research
por: Moher, David, et al.
Publicado: (2015)

National Cancer Institute's leadership role in promoting State and Community Tobacco Control research
por: Ginexi, Elizabeth M, et al.
Publicado: (2016)

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
por: Mayer, Erica L, et al.
Publicado: (2007)

The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group
por: Courneya, K.S., et al.
Publicado: (2008)

Intestinal occlusion by gynecological cancers treated by percutaneous endoscopic gastrostomy and lanreotide: an Aviano National Cancer Institute experience
por: Budel, Martina, et al.
Publicado: (2020)

Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182–185
por: Buckstein, R., et al.
Publicado: (2007)

Would program performance indicators and a nationally coordinated response accelerate the elimination of tuberculosis in Canada?
por: Heffernan, Courtney, et al.
Publicado: (2018)

An Appetite for Modernizing the Regulatory Framework for Protein Content Claims in Canada
por: Marinangeli, Christopher P. F., et al.
Publicado: (2017)

Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium
Publicado: (2021)

Social, political, commercial, and corporate determinants of rural health equity in Canada: an integrated framework
por: Leimbigler, Betsy, et al.
Publicado: (2022)

Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding
por: Hobson, Robert W, et al.
Publicado: (2001)

First Nations Approaches to Childhood Obesity: Healthy Lifestyles in Canada Compared with Alternatives for Alaska Native Communities
por: de Schweinitz, Peter A., et al.
Publicado: (2017)

Evolving a national clinical trials learning health system
por: Stensland, Kristian D., et al.
Publicado: (2022)

Addition of lenalidomide to melphalan in the treatment of newly diagnosed multiple myeloma: the National Cancer Institute of Canada Clinical Trials Group MY.11 trial
por: White, D.J., et al.
Publicado: (2007)

Clinical Utility of Genomic Testing in Cancer Care
por: Pritchard, Daryl, et al.
Publicado: (2022)

Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome
por: Pelle, Fabio, et al.
Publicado: (2020)

Researching Prescription Drug Misuse among First Nations in Canada: Starting from a Health Promotion Framework
por: Dell, Colleen Anne, et al.
Publicado: (2012)

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
por: Gagnon, Marc-André
Publicado: (2020)

Trials are already being prioritised, just not at the institutional level
por: Kolstoe, Simon
Publicado: (2017)

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial
por: Martinez, Juana, et al.
Publicado: (2022)

Optimizing the data available via Health Canada’s clinical information portal
por: Egilman, Alexander C., et al.
Publicado: (2021)

Climate Change, Human Health, and Biomedical Research: Analysis of the National Institutes of Health Research Portfolio
por: Jessup, Christine M., et al.
Publicado: (2013)

Report on the National Eye Institute’s Audacious Goals Initiative: Creating a Cellular Environment for Neuroregeneration
por: Burns, Marie E., et al.
Publicado: (2018)

Leaving no stone unturned: The National Institute of Dental and Craniofacial Research’s scientific response to COVID-19
por: D’Souza, Rena N., et al.
Publicado: (2021)

Delivery of Cancer Care in India and Canada: Opportunities for Bidirectional Learning
por: Cyriac, Sunu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cjh8nfntm29pctce2qf9tn1fj0